Alnylam Pharmaceuticals (ALNY) EBIT Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.96% |
| Dec 31, 2025 | 39.22% |
| Sep 30, 2025 | 50.75% |
| Jun 30, 2025 | 56.12% |
| Mar 31, 2025 | 28.53% |
| Dec 31, 2024 | 18.54% |
| Sep 30, 2024 | 24.92% |
| Jun 30, 2024 | 32.62% |
| Mar 31, 2024 | 38.45% |
| Dec 31, 2023 | 15.69% |
| Sep 30, 2023 | 43.41% |
| Jun 30, 2023 | -4.94% |
| Mar 31, 2023 | 10.67% |
| Dec 31, 2022 | 14.15% |
| Sep 30, 2022 | -6.06% |
| Jun 30, 2022 | 6.73% |
| Mar 31, 2022 | 8.06% |
| Dec 31, 2021 | 4.07% |
| Sep 30, 2021 | 10.63% |
| Jun 30, 2021 | 8.75% |
| Mar 31, 2021 | -8.11% |
| Dec 31, 2020 | -9.66% |
| Sep 30, 2020 | -21.42% |
| Jun 30, 2020 | -18.18% |
| Mar 31, 2020 | -25.42% |
| Dec 31, 2019 | -37.19% |
| Sep 30, 2019 | -26.57% |
| Jun 30, 2019 | -36.72% |
| Mar 31, 2019 | -19.72% |
| Dec 31, 2018 | -33.55% |
| Sep 30, 2018 | -48.12% |
| Jun 30, 2018 | -38.16% |
| Mar 31, 2018 | -41.33% |
| Dec 31, 2017 | -47.70% |
| Sep 30, 2017 | -40.66% |
| Jun 30, 2017 | -38.85% |
| Mar 31, 2017 | 26.57% |
| Dec 31, 2016 | -57.42% |
| Sep 30, 2016 | -49.02% |
| Jun 30, 2016 | -63.09% |
| Mar 31, 2016 | -123.89% |
| Dec 31, 2015 | -1.55% |
| Sep 30, 2015 | -62.82% |
| Jun 30, 2015 | -82.16% |
| Mar 31, 2015 | -68.62% |
| Dec 31, 2014 | -49.85% |
| Sep 30, 2014 | -53.74% |
| Jun 30, 2014 | -50.82% |
| Mar 31, 2014 | -157.95% |
| Dec 31, 2013 | -33.60% |
| Sep 30, 2013 | -54.57% |
| Jun 30, 2013 | -22.39% |
| Mar 31, 2013 | 4.64% |
| Dec 31, 2012 | -122.06% |
| Sep 30, 2012 | -23.43% |
| Jun 30, 2012 | 18.65% |